Pulmatrix Inc Share Price Nasdaq
Equities
US74584P1030
Biotechnology & Medical Research
Sales 2022 | 6.07M 476M | Sales 2023 | 7.3M 572M | Capitalization | 6.79M 532M |
---|---|---|---|---|---|
Net income 2022 | -18M -1.41B | Net income 2023 | -14M -1.1B | EV / Sales 2022 | -3.4 x |
Net cash position 2022 | 34.77M 2.72B | Net cash position 2023 | 10.42M 816M | EV / Sales 2023 | -0.5 x |
P/E ratio 2022 |
-0.71
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 02/05/17 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 17/04/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 31/10/19 |
Director/Board Member | 54 | 22/06/20 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 30/09/20 |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |